Why do amitriptyline and dothiepin appear to be so dangerous in overdose?
- PMID: 2589103
- DOI: 10.1111/j.1600-0447.1989.tb03046.x
Why do amitriptyline and dothiepin appear to be so dangerous in overdose?
Abstract
Data from different analyses of reported deaths from overdose with antidepressants in the U.K. reveal that amitriptyline and dothiepin are the antidepressants most likely to be associated with death from overdose. All widely used tricyclic antidepressants (TCAs) except clomipramine and lofepramine appear to be dangerous in overdose, whereas the newer antidepressants such as mianserin, trazodone, viloxazine and the TCA lofepramine appear to be relatively safe. The toxicity of amitriptyline and dothiepin appears to be greater than all antidepressants including other TCAs and it is important to try to understand why. A number of explanations will be considered: 1. Dothiepin and amitriptyline may be inherently more toxic than other TCAs. 2. Dothiepin and amitriptyline may induce suicide more than other antidepressants. It is assumed that antidepressants are neutral with regard to inducing suicide but this may not be true. There is, for example, evidence that alprazolam and other benzodiazepines induce suicidal behaviour. 3. Amitriptyline and dothiepin are often presented in subtherapeutic and ineffective doses and it is possible that increased suicides may result from inadequately treated depression. 4. There may be a selective overreporting of deaths with amitriptyline and dothiepin. 5. Amitriptyline and prothiaden may be selectively given to the suicide prone on the mistaken assumption that they are safe.
Similar articles
-
Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants.Lancet. 1994 Jan 15;343(8890):159-62. doi: 10.1016/s0140-6736(94)90940-7. Lancet. 1994. PMID: 7904010
-
Why do fatal overdose rates vary between antidepressants?Acta Psychiatr Scand Suppl. 1989;354:25-35. doi: 10.1111/j.1600-0447.1989.tb03044.x. Acta Psychiatr Scand Suppl. 1989. PMID: 2589101
-
The cardiovascular safety of tricyclic antidepressants in overdose and in clinical use.Ther Adv Psychopharmacol. 2024 May 30;14:20451253241243297. doi: 10.1177/20451253241243297. eCollection 2024. Ther Adv Psychopharmacol. 2024. PMID: 38827015 Free PMC article. Review.
-
The toxicity of drugs used for suicide.Acta Psychiatr Scand Suppl. 1993;371:33-7. doi: 10.1111/j.1600-0447.1993.tb05371.x. Acta Psychiatr Scand Suppl. 1993. PMID: 8517181 Review.
-
Fatal toxicity of antidepressant drugs in overdose.Br Med J (Clin Res Ed). 1987 Oct 24;295(6605):1021-4. doi: 10.1136/bmj.295.6605.1021. Br Med J (Clin Res Ed). 1987. PMID: 3690249 Free PMC article.
Cited by
-
Suicidal antidepressant overdoses: a comparative analysis by antidepressant type.J Med Toxicol. 2008 Dec;4(4):238-50. doi: 10.1007/BF03161207. J Med Toxicol. 2008. PMID: 19031375 Free PMC article.
-
Recurrent overdose: patient characteristics, habits, and outcomes.J Accid Emerg Med. 1998 Jul;15(4):257-61. doi: 10.1136/emj.15.4.257. J Accid Emerg Med. 1998. PMID: 9681311 Free PMC article.
-
Antidepressant drugs and the emergence of suicidal tendencies.Drug Saf. 1993 Mar;8(3):186-212. doi: 10.2165/00002018-199308030-00002. Drug Saf. 1993. PMID: 8452661 Review.
-
Effective and acceptable treatment for depression.BMJ. 1993 Apr 24;306(6885):1126. doi: 10.1136/bmj.306.6885.1126-b. BMJ. 1993. PMID: 8495171 Free PMC article. No abstract available.
-
Cost utility of maintenance treatment of recurrent depression with sertraline versus episodic treatment with dothiepin.Pharmacoeconomics. 1994 Mar;5(3):249-68. doi: 10.2165/00019053-199405030-00008. Pharmacoeconomics. 1994. PMID: 10146899
MeSH terms
Substances
LinkOut - more resources
Medical